Advancing Cancer Diagnostics
Welcome to Cellda AB, where innovation transforms cancer detection. Our state-of-the-art technology, Cellda® Image Analysis Suite, applied on our first product Cellda ® Prostate, delivers faster, more accurate, and objective diagnoses and thereby provides possibility for improving patient care and outcomes. Join us in shaping the future of cancer diagnostics
2018
Founded
10 MSEK
In capital
10 000
New prostate cancer cases every year in Sweden
1,4 million
Cases worldwide
Message from the CEO
“We're at the forefront of cancer diagnostics”
…pioneering innovative solutions for prostate diagnosis. Our commitment to excellence drives us to create cutting-edge technology that revolutionizes healthcare. Join us on this journey towards a healthier future.
– Susanne Bredenberg, CEO Cellda AB
Understanding Prostate Cancer
Prostate cancer is a prevalent and often life-altering disease that affects millions of men worldwide. It is the second most commonly diagnosed cancer among men, following lung cancer. This condition demands our attention, research, and innovative solutions to improve early detection, diagnosis, and treatment. At Cellda AB, we are dedicated to pioneering advancements in prostate cancer diagnostics to enhance patient outcomes and reduce the burden of this disease on individuals and their families. Join us in the fight against prostate cancer and explore how our cutting-edge technology is making a difference.
Our Commitment to Excellence
We are dedicated to pioneering cancer diagnostics. Our team, comprising experts in pathology and software development, strives for accuracy and reliability. We’re driven by the mission to improve patient care, lower healthcare costs, and advance medical research. Join us in the fight against cancer.
